Pharma's Almanac

39 Articles Available

0 2

Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

PAO-09-022-CL-05

Antibiotic Resistance

Antibiotic Resistance: Advances in Understanding and Drug Development

PAO-10-022-NI-07

Column: New Drug Watch

Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand

PAO-10-022-NI-06

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

PAO-10-022-NI-01

mRNA

Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties

PAO-10-022-NI-02

Precision Medicine

Examining the Potential of Precision/Personalized Medicine

PAO-10-022-NI-03

Column: Supply Chain

Reimagining the Pharmaceutical Supply Chain

PAO-10-022-NI-04

Big Data

Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More

PAO-10-022-NI-05

Future of the Industry

What key indicators do you look at to predict the future of this industry?

PAO-10-022--RT-02

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

PAO-10-022--RT-01

Transient Expression

Overcoming Limitations with Transient Protein Expression to Accelerate Development

PAO-10-022-CL-02

Clinical Workflow Integration

How All Clinical Trial Stakeholders Can Collaborate as One Study Team

PAO-10-022-CL-01

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

PAO-09-022-CL-07

Real-Time Monitoring

Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing

PAO-09-022-CL-08

Digital Health Solutions

Beyond Drug Sales: Adding Value with Digital Health

PAO-08-022-CL-05

Neurodegenerative Disease Clinical Trials

Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants

PAO-09-022-CL-09

Clinical Trials Adherence

Evolving Solutions to Optimize Clinical Trial Decentralization

PAO-09-022-CL-06

Biodefense

Supporting Biodefense Countermeasures with Strong Capabilities and Expertise

PAO-09-022-CL-03

Speed to Clinic

Leveraging Experience to Reduce Timelines for IND-Enabling Activities

PAO-09-022-CL-04

CDMO

Asymchem: Leading with Technology

PAO-09-022-CL-01

Diversity and Inclusion

Five Ways to Embed Truly Diverse and Inclusive Patient Engagement into Pharma’s DNA

PAO-09-022-CL-02

Plant-Inspired Drug Discovery

Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures

PAO-08-022-CL-01

Cosmeceuticals

Cosmeceuticals Are Here. When Will Regulations Catch Up?

PAO-08-022-CL-09

Theranostics

Theranostic Manufacturing Solutions

PAO-08-022-CL-07

0 2

Q32022